Customer 4 Customer Four [Member] Customer Four Statistical Measurement Statistical Measurement [Domain] Schedule of Unrealized Gains Debt Securities, Available-for-Sale [Table Text Block] Software Prepaid Software, Current Prepaid Software, Current Award Timing Predetermined Award Timing Predetermined [Flag] Year ended December 31, 2026 Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Entity File Number Entity File Number Additional Paid in Capital Additional Paid-in Capital [Member] Valuation Approach and Technique [Domain] Valuation Approach and Technique [Domain] Tabular List, Table Tabular List [Table Text Block] Leases [Abstract] Leases [Abstract] Series F-1 Series F1 Preferred Stock [Member] Series F1 Preferred Stock. Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Interest income Interest Income (Expense), Nonoperating Stock options and Restricted Stock Units Share-Based Payment Arrangement [Member] Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Outstanding, beginning of period (in shares) Outstanding, end of period (in shares) Outstanding number of warrants (in shares) Class of Warrant or Right, Outstanding Basic (loss) income per common share (in dollars per share) Earnings Per Share, Basic Adjustment to Compensation: Adjustment to Compensation [Axis] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Unobservable Inputs In Valuation Unobservable Inputs In Valuation [Member] Unobservable Inputs In Valuation Accounts payable and accrued expenses Increase (Decrease) in Accounts Payable and Accrued Liabilities Liabilities: Liabilities, Fair Value Disclosure [Abstract] Common stock, capital shares reserved (in shares) Common Stock, Capital Shares Reserved for Future Issuance Revenue Revenue from Contract with Customer [Text Block] Schedule of Stock by Class [Table] Stock, Class of Stock [Table] Measurement Input, Discount Rate Measurement Input, Discount Rate [Member] Inventory Disclosure [Abstract] Inventory Disclosure [Abstract] Maximum aggregate offering price of securities under shelf registration Maximum Aggregate Offering Price Of Securities Under Shelf Registration Maximum Aggregate Offering Price Of Securities Under Shelf Registration Issuance of common stock with the Employee Stock Purchase Plan (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Area of space Area of Real Estate Property Measurement Input Type Measurement Input Type [Domain] Series E-1 Series E1 Preferred Stock [Member] Series e1 preferred stock member Warrants exercised (in dollars per share) Class Of Warrant Or Right Weighted Average Exercise Price Exercised Class Of Warrant Or Right Weighted Average Exercise Price Exercised Adjustment to Compensation, Amount Adjustment to Compensation Amount Concentration risk, percentage Concentration Risk, Percentage Stock options and Restricted Stock Units Share-Based Payment Arrangement, Option [Member] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Schedule Of Property Plant And Equipment [Table] Property, Plant and Equipment [Table] Taxes Prepaid Taxes Stockholders Equity Note [Table] Stockholders Equity Note [Table] Stockholders equity note. Antidilutive Securities [Axis] Antidilutive Securities [Axis] Warrants canceled (in shares) Class Of Warrant Or Right Cancelled Class Of Warrant Or Right Exercised. Total stockholders’ equity Beginning balance Ending balance Equity, Attributable to Parent Debt Securities, Available-for-sale [Table] Debt Securities, Available-for-Sale [Table] Other comprehensive income (loss): Other Comprehensive Income (Loss), Net of Tax [Abstract] Insider Trading Policies and Procedures [Line Items] Total Share-Based Payment Arrangement, Expense Warrant Exercise - Series F Stock Issued During Period Value Exercise Of Warrants Stock Issued During Period Value Exercise Of Warrants Schedule of Property, Plant, and Equipment Property, Plant and Equipment [Table Text Block] Common stock, shares authorized (in shares) Common Stock, Shares Authorized Current assets Assets, Current [Abstract] Cancelled/Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Total liabilities and stockholders’ equity Liabilities and Equity Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Annual rent expense Lessee, Operating Lease, Contractual Annual Rent Expense Lessee, Operating Lease, Contractual Annual Rent Expense Number of Options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Liquidity Liquidity And Going Concern Policy [Policy Text Block] Liquidity and going concern. Beginning of period End of period Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation Liabilities and Stockholders’ Equity Liabilities and Equity [Abstract] Schedule of Employee Stock Ownership Plan (ESOP) Disclosures [Table] Employee Stock Ownership Plan (ESOP) [Table] Cover [Abstract] Cover [Abstract] Money market funds Cash and Cash Equivalents, Fair Value Disclosure Maximum Maximum [Member] Weighted Average Exercise Price, Exercisable (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Accounting Policies [Abstract] Accounting Policies [Abstract] Schedule of Remaining Maturity of Operating Leases Excluding Short-term Leases Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount May 2022 Employee Stock Purchase Plan May Two Thousand And Twenty Two Employee Stock Purchase Plan [Member] May two thousand and twenty two employee stock purchase plan member. Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Pay vs Performance Disclosure [Line Items] Class of Warrant or Right Class of Warrant or Right [Axis] Operating lease liabilities included in the condensed consolidated balance sheets at March 31, 2026 Operating Lease, Liability U.S. government agency bonds US Government Agencies Debt Securities [Member] Series B Series B Preferred Stock [Member] Foreign currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] (Loss) income before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Entity Shell Company Entity Shell Company Other liabilities, non-current Other Liabilities, Noncurrent Lease Arrangement [Axis] Lease Arrangement [Axis] Lease Arrangement Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Thereafter Lessee, Operating Lease, Liability, to be Paid, Due after Year Four Lessee, Operating Lease, Liability, to be Paid, Due after Year Four Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Company Selected Measure Amount Company Selected Measure Amount Year ended December 31, 2029 Lessee, Operating Lease, Liability, to be Paid, Year Three Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Other liabilities, non-current Increase (Decrease) in Other Noncurrent Liabilities Total comprehensive (loss) income Comprehensive Income (Loss), Net of Tax, Attributable to Parent Measurement Input Type Measurement Input Type [Axis] Expired (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Exercise Price Range Exercise Price Range [Axis] Name Measure Name Professional fees Prepaid Expense and Other Assets, Current [Abstract] Schedule of Recognized Share-based Compensation Cost Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Amortization of premiums and discounts on marketable securities Investment Income, Net, Amortization of Discount and Premium Lease liabilities, current Operating Lease, Liability, Current Schedule of Level 3 Investments Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Class of Stock [Line Items] Class of Stock [Line Items] Document Fiscal Period Focus Document Fiscal Period Focus $0.01 Exercise Price Range One [Member] Exercise Price Range One Award Timing Method Award Timing Method [Text Block] Furniture Furniture and Fixtures [Member] Award Type Award Type [Axis] Total assets Assets Trading Symbol Trading Symbol Year ended December 31, 2030 Lessee, Operating Lease, Liability, to be Paid, Year Four Vested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Geographical Geographical [Domain] Entity Address, City or Town Entity Address, City or Town Cash flows from operating activities: Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Preferred stock, shares designated (in shares) Preferred Stock, Shares, Designated Preferred Stock, Shares, Designated Equipment in process Equipment In Process [Member] Equipment In Process Concentration Risk Type [Axis] Concentration Risk Type [Axis] Inventory Inventory Disclosure [Text Block] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Income Statement Location Statement of Income Location, Balance [Domain] Restricted Stock Units (RSUs) Restricted Stock Units (RSUs) [Member] Total Cash and Cash Equivalents: Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation [Abstract] Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Weighted Average Remaining Contractual Term (in years), Unvested Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Remaining Contractual Term Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Remaining Contractual Term Assets: Assets, Fair Value Disclosure [Abstract] 2023 Plan 2023 Plan [Member] 2023 Plan Member Prepaid Expenses and Other Current Assets Prepaid Expenses And Other Current Assets [Text Block] Prepaid expenses and other current assets. Entity Emerging Growth Company Entity Emerging Growth Company Employee Stock Ownership Plan (ESOP) Disclosures [Line Items] Employee Stock Ownership Plan (ESOP) Disclosures [Line Items] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Employee stock purchase plan, offering period Share-based Compensation Arrangement By Share-based Payment Award, Stock Plan Offering Period Share-based Compensation Arrangement By Share-based Payment Award, Stock Plan Offering Period Debt Securities, Available-for-sale [Line Items] Debt Securities, Available-for-Sale [Line Items] Outstanding, beginning of period (in shares) Outstanding, end of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Significant Other Observable Inputs (Level 2) Fair Value, Inputs, Level 2 [Member] Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Measurement period (in year) Business Combination, Contingent Consideration, Liability, Measurement Period Business Combination, Contingent Consideration, Liability, Measurement Period Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Assumed conversion of preferred stock Assumed Conversion Of Preferred Stock [Member] Assumed conversion of preferred stock. Plan Name [Axis] Plan Name [Axis] PEO PEO [Member] Schedule of Revenue by Product Disaggregation of Revenue [Table Text Block] Maturities of investments Proceeds from Sale, Maturity and Collection of Investments U.S. United States UNITED STATES Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Stock Option Exercise Stock Issued During Period, Value, Stock Options Exercised Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Milestone payment unpaid Milestone Payment Unpaid Milestone payment unpaid. Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Accumulated Deficit Retained Earnings [Member] Prepaid expenses and other current assets Total prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Number of Restricted Stock Units Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Schedule of Accrued Expenses Schedule of Accrued Liabilities [Table Text Block] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Restatement Determination Date Restatement Determination Date Cash cash equivalents and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Income Statement [Abstract] Income Statement [Abstract] Income tax expense Income Tax Expense (Benefit) Measurement Input Probability of Payment Measurement Input Probability of Payment [Member] Measurement Input Probability of Payment Sale of Stock Sale of Stock [Domain] Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Aggregate Intrinsic Value, Unvested Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Unvested, Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Unvested, Intrinsic Value Product and Service Product and Service [Domain] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Customer Concentration Risk Customer Concentration Risk [Member] Property, plant and equipment, gross Property, Plant and Equipment, Gross Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Total Liabilities Liabilities, Fair Value Disclosure Customer 1 Customer One [Member] Customer One Amortization of Right-of-Use Asset Operating Lease, Right-of-Use Asset, Periodic Reduction Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Proceeds from exercise of stock options Proceeds from Stock Options Exercised City Area Code City Area Code Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] All Trading Arrangements All Trading Arrangements [Member] Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Accrued expenses Accrued expenses Accrued Liabilities, Current Change due to liability payment Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements Outstanding, beginning of period (in shares) Outstanding, end of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Class of Warrant or Right [Line Items] Class of Warrant or Right [Line Items] Cash flows from investing activities: Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Net cash provided by operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Unvested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares Schedule of Stock Option Activity Schedule of Stock Options Roll Forward [Table Text Block] Other information Other Lease Information [Abstract] Other lease information. Estimated Useful Life Property, Plant and Equipment, Useful Life Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Schedule of Assumptions to Estimate Fair Value of Stock Options Using Black-Scholes Option Pricing Model Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Selling, general and administrative Selling, General and Administrative Expenses [Member] Cost of goods sold Cost of Sales [Member] Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Schedule of Operating Leases Lease, Cost [Table Text Block] PEO Total Compensation Amount PEO Total Compensation Amount Depreciation expense Depreciation Outstanding, beginning of period (in dollars per share) Outstanding, ending of period (in dollars per share) Class Of Warrant Or Right Weighted Average Exercise Price Weighted average exercise price for warrants or rights outstanding. Stockholders Equity Note [Line Items] Stockholders Equity Note [Line Items] Stockholders equity note. Warrants exercised (in shares) Class Of Warrant Or Right Exercised Class Of Warrant Or Right Exercised. Equity Components Equity Components [Axis] Foreign Non-US [Member] Property Plant And Equipment [Line Items] Property, Plant and Equipment [Line Items] Weighted Average Exercise Price Class Of Warrant Or Right Weighted Average Exercise Price [Abstract] A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. Organization Consolidation Basis Of Presentation Business Description And Accounting Policies [Line Items] Organization Consolidation Basis Of Presentation Business Description And Accounting Policies [Line Items] Organization consolidation basis of presentation business description and accounting policies line item. Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Number of reportable segments Number of Reportable Segments Measurement input (in percent) Business Combination, Contingent Consideration, Liability, Measurement Input Equipment Equipment [Member] Expired (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period General Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost Other Performance Measure, Amount Other Performance Measure, Amount Weighted Average Exercise Price Per Share Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Inventory [Line Items] Inventory [Line Items] Entity Address, State or Province Entity Address, State or Province Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Security, Excluded EPS Calculation [Table] Supply agreement, renewal option term Supply Agreement, Renewal Option Term Supply Agreement, Renewal Option Term Total current liabilities Liabilities, Current Warrant Exercise - Series F (in shares) Stock Issued During Period Shares Exercise Of Warrants Stock Issued During Period Shares Exercise Of Warrants Clinical trial, number of patients Clinical Trial, Number Of Patients Clinical Trial, Number Of Patients Inventory [Axis] Inventory [Axis] Individual: Individual [Axis] Research and development Research and Development Expense [Member] Licenses Prepaid License, Current Prepaid License, Current Net cash used in investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Purchase obligation, next fiscal year Purchase Obligation, to be Paid, Year One Document Fiscal Year Focus Document Fiscal Year Focus Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Right-of-use assets Operating Lease, Right-of-Use Asset Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Entity Interactive Data Current Entity Interactive Data Current Plan Name [Domain] Plan Name [Domain] Cost expected to be recognized over weighted average period (in years) Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Stock Option Exercise (in shares) Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Aggregate Intrinsic Value, Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Buildings Building [Member] Business Combination, Contingent Consideration, Type [Axis] Business Combination, Contingent Consideration, Type [Axis] Warrants issued (in shares) Class Of Warrant Or Right Issued The number of each class of warrants or rights issued during the period. Segment Information Segment Reporting Disclosure [Text Block] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Term over which the royalty is to be paid Term Over Which The Royalty Is To Be Paid Term over which the royalty is to be paid. Long-Lived Tangible Asset Long-Lived Tangible Asset [Axis] Class of Warrant or Right [Table] Class of Warrant or Right [Table] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] HEPZATO KIT HEPZATO KIT [Member] HEPZATO KIT Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Contingent Liability Business Combination, Contingent Consideration, Liability Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Fair Value, Recurring and Nonrecurring [Table] Selling, general and administrative expenses Selling, General and Administrative Expense Series D Series D Preferred Stock [Member] Customer [Domain] Customer [Domain] Entity Central Index Key Entity Central Index Key PEO Name PEO Name Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Finished goods Finished goods Inventory, Finished Goods, Gross Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Land Improvements Land and Land Improvements [Member] Beginning balance Ending balance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Arrangement Duration Trading Arrangement Duration Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Enterprise hardware and software Computer Equipment [Member] Warrant exercise price (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets Exercise Price Award Exercise Price Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Entity Filer Category Entity Filer Category Class of Stock Class of Stock [Domain] Local Phone Number Local Phone Number Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Series F-3 Series F3 Preferred Stock [Member] Series F3 Preferred Stock. Inventory, Current [Table] Inventory, Current [Table] Warrants issued (in dollars per share) Class Of Warrant Or Right Weighted Average Exercise Price Issued Weighted average exercise price for the number of warrants or rights issued for the unvested, forfeitable warrants or rights in period. Repurchase and retirement of common stock (in shares) Stock repurchased and retired (in shares) Stock Repurchased and Retired During Period, Shares Series F Preferred Stock Series F Preferred Stock [Member] Weighted Average Remaining Contractual Term (in years), Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Remaining Contractual Term Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Remaining Contractual Term Assets Assets [Abstract] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Class of Warrant or Right Class of Warrant or Right [Domain] Other Commitments [Axis] Other Commitments [Axis] Forfeited (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Fair Value Measurements Fair Value Disclosures [Text Block] Stockholders’ equity Equity, Attributable to Parent [Abstract] Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Entity Address, Address Line One Entity Address, Address Line One Pre-funded warrants outstanding (in shares) Number Of Shares Pre Funded Penny Warrants Outstanding Number of shares pre-funded penny warrants outstanding. Research and development expenses Research and Development Expense Accumulated Other Comprehensive Income (Loss) AOCI Attributable to Parent [Member] Lease liabilities, non-current Operating Lease, Liability, Noncurrent Work-in-process Inventory, Work in Process, Gross Schedule of Designated Preferred Shares Schedule of Stock by Class [Table Text Block] Fair Value as of Grant Date Award Grant Date Fair Value Accounts receivable Accounts Receivable, after Allowance for Credit Loss Property, Plant and Equipment [Abstract] Property, Plant and Equipment [Abstract] Entity Registrant Name Entity Registrant Name Proceeds from exercise of warrants Proceeds from Warrant Exercises Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Minimum annual payments Minimum Annual Payments Minimum annual payments. 2021 Sub-Lease Sub-Lease 2021 [Member] Sub-Lease 2021 Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Purchase of investments Payments to Acquire Investments Unrecognized compensation expense related to non-vested share-based compensation awards Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Document Quarterly Report Document Quarterly Report Total Assets Assets, Fair Value Disclosure Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Interest receivable Interest receivable Interest Receivable, Current Counterparty Name [Domain] Counterparty Name [Domain] Year ended December 31, 2028 Lessee, Operating Lease, Liability, to be Paid, Year Two Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Weighted Average Remaining Contractual Term (in years), Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Title Trading Arrangement, Individual Title Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Restatement Determination Date: Restatement Determination Date [Axis] Warrants Warrants Outstanding Roll Forward A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. Non-PEO NEO Non-PEO NEO [Member] Aggregate Intrinsic Value, Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value % of Accounts Receivable Accounts Receivable [Member] Schedule of Prepaid Expenses and Other Current Assets Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block] Issuance of common stock with the Employee Stock Purchase Plan Stock Issued During Period, Value, Employee Stock Purchase Plan HEPZATO KIT, Doxorubicin HEPZATO KIT, Doxorubicin [Member] HEPZATO KIT, Doxorubicin Sale of Stock Sale of Stock [Axis] Gross Unrealized Gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Name Trading Arrangement, Individual Name Award Type Award Type [Domain] Year ended December 31, 2027 Lessee, Operating Lease, Liability, to be Paid, Year One Equity Awards Adjustments Equity Awards Adjustments [Member] Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Organization Consolidation Basis Of Presentation Business Description And Accounting Policies [Table] Organization Consolidation Basis Of Presentation Business Description And Accounting Policies [Table] Organization consolidation basis of presentation business description and accounting policies table. Compensation Amount Outstanding Recovery Compensation Amount Expected dividends Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Liability fair value adjustment Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Fair Value Adjustment Gain (Loss) Included in Earnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Fair Value Adjustment Gain (Loss) Included in Earnings Preferred Stock Preferred Stock [Member] MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Name Awards Close in Time to MNPI Disclosures, Individual Name Outstanding, beginning of period (in dollars per share) Outstanding, end of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Total change in foreign exchange Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Foreign Exchange Gain (Loss) Included in Earnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Foreign Exchange Gain (Loss) Included in Earnings Contingent liabilities Contingent Liabilities [Member] Contingent liabilities. Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] June 2024 Shelf Registration Statement June 2024 Shelf Registration Statement [Member] June 2024 Shelf Registration Statement Employee Stock Purchase Plan Assumed conversion of ESPP Employee Stock [Member] Deposit assets Deposit Assets Commitments and Contingencies Commitments Disclosure [Text Block] Inventory [Domain] Inventory [Domain] Stock option compensation expense Stock Option Compensation Income Expense Stock option compensation (income) expense. Accumulated other comprehensive income Accumulated Other Comprehensive Income (Loss), Net of Tax Professional services Prepaid Professional Services Current Prepaid professional services current. Financial Instruments [Domain] Financial Instruments [Domain] Liability Class [Axis] Liability Class [Axis] Income Statement Location Statement of Income Location, Balance [Axis] Investments Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Inventories Increase (Decrease) in Inventories Inventories Total inventory Inventory, Net Minimum Minimum [Member] Accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Company Selected Measure Name Company Selected Measure Name Preferred stock, $0.01 par value; 10,000,000 shares authorized; 14,192 and 14,192 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively Preferred Stock, Value, Issued Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Accounts payable Accounts Payable, Current Operating cash flows for operating leases Operating Lease, Payments Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] All Executive Categories All Executive Categories [Member] Stockholders' Equity Note [Abstract] Stockholders' Equity Note [Abstract] Loss contingency accrual, non-current Loss Contingency, Accrual, Noncurrent Common stock, $0.01 par value; 80,000,000 shares authorized; 34,465,087 shares and 34,691,671 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively Common Stock, Value, Issued Weighted average number of diluted shares outstanding (in shares) Weighted average shares outstanding, diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Commitments and contingencies (see Note 12) Commitments and Contingencies Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Number of orphan drug designations granted by FDA Number of Orphan Drug Designations Granted by US Food and Drug Administration Number of Orphan Drug Designations Granted by US Food and Drug Administration Queensbury Lease Queensbury Lease [Member] Queensbury Lease Other Other Prepaid Expense, Current Entity Small Business Entity Small Business Clinical expenses Accrued Clinical Expenses Current Accrued Clinical Expenses Current Schedule of Revenue by Location Revenue from External Customers by Geographic Areas [Table Text Block] Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Document Transition Report Document Transition Report Schedule of Information Related to Stock Warrants Outstanding and Exercisable Schedule Of Information Related To Stock Warrants Outstanding And Exercisable [Table Text Block] Schedule of Information Related to Stock Warrants Outstanding and Exercisable. Schedule of Revenue and Accounts Receivable Concentrations Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Underlying Securities Award Underlying Securities Amount Equity Component Equity Component [Domain] Document Period End Date Document Period End Date Medac Medac [Member] Medac. PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Income Taxes Income Tax Disclosure [Text Block] medac Other Liabilities, Future Sales, Current Other Liabilities, Future Sales, Current Lease Arrangement [Domain] Lease Arrangement [Domain] Lease Arrangement [Domain] Customer 3 Customer Three [Member] Customer Three Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] Clinical trial expenses Prepaid Clinical Trial Expenses Current Prepaid clinical trial expenses current. Weighted Average Remaining Contractual Term (in years), Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Clinical trial, number of sites (more than) Clinical Trial, Number Of Sites Clinical Trial, Number Of Sites Shares acquired, average cost (in dollars per share) Shares Acquired, Average Cost Per Share Inventory held at hospitals and treatment centers Inventory Held At Hospitals And Treatment Centers [Member] Inventory Held At Hospitals And Treatment Centers Document Type Document Type Significant Unobservable Inputs (Level 3) Fair Value, Inputs, Level 3 [Member] Net (Loss) Income per Share Earnings Per Share [Text Block] Name Outstanding Recovery, Individual Name Loss Contingencies [Table] Loss Contingencies [Table] Additional paid-in capital Additional Paid in Capital Product and Service [Axis] Product and Service [Axis] Product and Service [Axis] Business Combination, Contingent Consideration, Type [Domain] Business Combination, Contingent Consideration, Type [Domain] Proceeds from the issuance of common stock relating to the employee stock purchase plan Proceeds from Issuance of Common Stock % of Revenue Revenue from Contract with Customer Benchmark [Member] Product revenue Total revenue Revenue from Contract with Customer, Excluding Assessed Tax All Individuals All Individuals [Member] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Purchase of property, plant and equipment Payments to Acquire Property, Plant, and Equipment Name Forgone Recovery, Individual Name Total current assets Assets, Current Statistical Measurement Statistical Measurement [Axis] Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Loss contingency accrual Loss Contingency Accrual Share repurchase program, authorized Share Repurchase Program, Authorized, Amount Weighted average shares issued (in shares) Weighted Average Number of Shares Issued, Basic Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Purchase price of common stock (as a percent) Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent Intrinsic value of stock options exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Inventory Accrued Inventory, Current Accrued Inventory, Current Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Current liabilities Liabilities, Current [Abstract] Weighted Average Remaining Contractual Term (in years) and Aggregate Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] Geographical Geographical [Axis] Lessee Lease Description [Line Items] Lessee, Lease, Description [Line Items] Total operating expenses Operating Expenses Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Quoted Prices in Active Markets (Level 1) Fair Value, Inputs, Level 1 [Member] Beginning balance (in shares) Ending balance (in shares) Shares, Outstanding Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items] Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items] Diluted (loss) income per common share (in dollars per share) Earnings Per Share, Diluted Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Title of 12(b) Security Title of 12(b) Security Lessee Lease Description [Table] Lessee, Lease, Description [Table] Agreements relating to clinical trial support Agreements Relating to Clinical Trial Support [Member] Agreements Relating to Clinical Trial Support Insurance premiums Prepaid Insurance HEPZATO KIT, Melphalan HEPZATO KIT, Melphalan [Member] HEPZATO KIT, Melphalan Compensation expense for issuance of stock options APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition Common share data: Earnings Per Share [Abstract] Investments, Debt and Equity Securities [Abstract] Gross profit Gross Profit Schedule of Potentially Dilutive Securities Excluded from the Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Weighted average pre-funded warrants (in shares) Weighted Average Number Of Shares Pre Funded Warrants Weighted average number of shares pre funded warrants 1. Short-term investments Estimated Fair Value Debt Securities, Available-for-Sale, Current Repurchase and retirement of common stock Stock repurchased and retired Stock Repurchased and Retired During Period, Value Product reimbursement period Product Reimbursement Period Product Reimbursement Period Accrued Expenses Accounts Payable and Accrued Liabilities Disclosure [Text Block] Less present value discount Lessee, Operating Lease, Liability, Undiscounted Excess Amount Exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Award Timing Disclosures [Line Items] Schedule of Inventory Schedule of Inventory, Current [Table Text Block] Granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Compensation, excluding taxes Employee-related Liabilities, Current Property, Plant, and Equipment Property, Plant and Equipment Disclosure [Text Block] Total Lessee, Operating Lease, Liability, to be Paid Extension term Lessee, Operating Lease, Renewal Term Stockholders' Equity Equity [Text Block] Net (loss) income Net income (loss) Net (loss) income Net Income (Loss) Attributable to Parent Weighted Average Exercise Price, Unvested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Unvested, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Unvested, Weighted Average Exercise Price Expiration Date Trading Arrangement Expiration Date Other Commitments [Domain] Other Commitments [Domain] Other Other Accrued Liabilities, Current Unrealized gain on investments adjustments Unrealized gain on investment adjustments Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent Property, plant and equipment, net Property, plant and equipment, net Property, Plant and Equipment, Net Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Repurchase and retirement of common stock Payments for Repurchase of Common Stock Adoption Date Trading Arrangement Adoption Date Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Accounts receivable Increase (Decrease) in Accounts Receivable Series A Series A Preferred Stock [Member] Entity Current Reporting Status Entity Current Reporting Status Lease term Lessee, Operating Lease, Term of Contract Measurement Input, Expected Term Measurement Input, Expected Term [Member] Customer [Axis] Customer [Axis] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Operating (loss) income Operating Income (Loss) Accumulated deficit Retained Earnings (Accumulated Deficit) Leaseholds Leaseholds and Leasehold Improvements [Member] Warrants canceled (in dollars per share) Class Of Warrant Or Right Weighted Average Exercise Price Cancelled Class Of Warrant Or Right Weighted Average Exercise Price Cancelled Financial Instrument [Axis] Financial Instrument [Axis] CHEMOSAT CHEMOSAT [Member] CHEMOSAT Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Executive Category: Executive Category [Axis] Loss contingency accrual, current Loss Contingency, Accrual, Current Liability fair value adjustment Fair Value Recurring Basis, Unobservable Input Reconciliation, Liability, Gain (Loss), Statement Of Income Extensible List Not Disclosed Flag Fair Value Recurring Basis, Unobservable Input Reconciliation, Liability, Gain (Loss), Statement Of Income Extensible List Not Disclosed Flag Inventory reserve Inventory Valuation Reserves Class of Stock Class of Stock [Axis] Current Fiscal Year End Date Current Fiscal Year End Date Ireland IRELAND Expected terms (years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Payables and Accruals [Abstract] Payables and Accruals [Abstract] Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Number of shares available for grant (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Statement [Table] Statement [Table] Other (expense) income Other Nonoperating Income (Expense) Foreign currency effects on cash Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation Adjustments to reconcile net (loss) income to net cash used in operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Cash flows from financing activities: Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Weighted average grant-date fair value of the stock options granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Customer 2 Customer Two [Member] Customer Two Series C Series C Preferred Stock [Member] Antidilutive securities excluded from computation of earnings per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] All Adjustments to Compensation All Adjustments to Compensation [Member] Amendment Flag Amendment Flag Number of shares authorized (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Leases Lessee, Operating Leases [Text Block] Termination Date Trading Arrangement Termination Date Net cash (used in) provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Measure: Measure [Axis] Valuation Approach and Technique [Axis] Valuation Approach and Technique [Axis] Weighted average discount rate - operating leases Operating Lease, Weighted Average Discount Rate, Percent Schedule of Warrant Activity Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Long-Lived Tangible Asset Long-Lived Tangible Asset [Domain] Weighted average number of basic shares outstanding (in shares) Weighted average shares outstanding, basic (in shares) Weighted Average Number of Shares Outstanding, Basic Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share repurchase program, remaining authorized, amount Share Repurchase Program, Remaining Authorized, Amount Exercisable (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Exercise Price Range Exercise Price Range [Domain] Buildings and land Land, Buildings and Improvements [Member] Subsequent Events [Abstract] Segment Reporting [Abstract] Cost of goods sold Cost of Revenue Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Operating lease expense Operating Lease, Expense Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Series F-4 Series F4 Preferred Stock [Member] Series F4 Preferred Stock. Entity Tax Identification Number Entity Tax Identification Number Valuation Technique, Discounted Cash Flow Valuation Technique, Discounted Cash Flow [Member] Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table] Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table] Warrants Class Of Warrant Or Right Outstanding [Roll Forward] Class Of Warrant Or Right Outstanding Outstanding, beginning of period (in dollars per share) Outstanding, end of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Schedule of Reconciliation of Weighted Average Shares Outstanding Calculation Schedule of Weighted Average Number of Shares [Table Text Block] Common stock, shares issued (in shares) Common Stock, Shares, Issued Weighted average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Trading Arrangement: Trading Arrangement [Axis] Total Shareholder Return Amount Total Shareholder Return Amount Loss Contingencies [Line Items] Loss Contingencies [Line Items] Series E Series E Preferred Stock [Member] Schedule of Financial Assets and Liabilities Measured at Fair Value Fair Value Measurements, Recurring and Nonrecurring [Table Text Block] Subsequent Events Subsequent Events [Text Block] Insider Trading Arrangements [Line Items] Security Exchange Name Security Exchange Name Cancelled/Forfeited (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 2020 Plan 2020 Plan [Member] 2020 Plan Raw materials Inventory, Raw Materials, Gross Total liabilities Liabilities Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Series F-2 Series F2 Preferred Stock [Member] Series F2 Preferred Stock. Operating expenses: Operating Expenses [Abstract] Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] ESPP withholding Employee Stock Purchase Plan Withholding, Current Employee Stock Purchase Plan Withholding ,Current Statement [Line Items] Statement [Line Items] Common Warrants Common Warrants [Member] Common Warrants Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Cash and cash equivalents Cash and Cash Equivalent Counterparty Name [Axis] Counterparty Name [Axis] Schedule of Restricted Stock Units Granted Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] Common Stock Common Stock [Member] U.S. government agency bonds Debt Securities, Available-for-Sale Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Risks and Uncertainties Risk And Uncertainties Policy [Policy Text Block] Risk and uncertainties. Non-NEOs Non-NEOs [Member] Net decrease in total cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Additional dilutive shares (in shares) Weighted Average Number of Shares Outstanding, Diluted, Adjustment Professional fees Accrued Professional Fees, Current